Aisa Pharma's AISA-021 Shows Promise in Raynaud's Treatment
Aisa Pharma reports positive outcomes from its Phase 2 trial of AISA-021, indicating potential new treatment for Raynaud's phenomenon linked to system...
Dimensional Fund Advisors Discloses Stake in Spire Healthcare
Dimensional Fund Advisors Ltd. reveals its stake in Spire Healthcare Group PLC, owning over 1% of its ordinary shares, signaling strong investor confi...
Pregnant Women Reduce Tylenol Use Following Trump’s Autism Claims
Pregnant women are increasingly avoiding Tylenol after Donald Trump's autism claims, with emergency rooms seeing a 30% decline in its use among expect...
Alarming Rise in Heart Disease Among Young Women
Heart disease deaths among young women are rising alarmingly. Awareness of symptoms and risk factors is crucial for prevention.
Minneapolis' Health Networks: A Model for Other Cities?
Minneapolis' underground health networks for immigrants could inspire similar initiatives in other cities facing ICE enforcement actions.
Investors Eye Booming Retinal Vein Occlusion Market to 2034
The retinal vein occlusion market is projected to grow significantly by 2034, attracting major investors and companies like Kodiak Sciences and Roche.
OLLY Unveils Sleep House Sweepstakes Amid National Sleep Month
OLLY launches a Sleep House Sweepstakes this March, offering a chance to win a retreat in Joshua Tree and promote sleep awareness.
Skeletal Dysplasia Market Set to Reach $5.37 Billion by 2032
The skeletal dysplasia market is projected to reach $5.37 billion by 2032, driven by advancements in diagnostics and integrated therapies.
Chile Achieves Historic Milestone in Leprosy Elimination
Chile is the first country in the Americas to be verified by WHO for the elimination of leprosy, marking a significant public health achievement.


